In this presentation, we welcome Aytu BioPharma, NASDAQ ticker symbol, AYTU. And with us today is their Chief Executive Officer, Josh Disbrow. Aytu BioPharma is a pharmaceutical company commercializing a portfolio of commercial prescription therapeutics.

This Fireside Chat was recorded during the Lytham Partners Summer 2022 Investor Conference.